This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
ORIGINAL RESEARCH PAPER
Gao, M. et al. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465, 96–100 (2010)
FURTHER READING
O'Boyle II, D. R. et al. Development of a cell-based high-throughput specificity screen using a hepatitis C virus–bovine viral diarrhea virus dual replicon assay. Antimicrob. Agents Chemother. 49, 1346–1353 (2005)
Lemm, J. A. et al. Identification of hepatitis C virus NS5A inhibitors. J. Virol. 84, 482–491 (2010)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tse, M. New oral HCV drug shows promise. Nat Rev Microbiol 8, 464–465 (2010). https://doi.org/10.1038/nrmicro2396
Issue Date:
DOI: https://doi.org/10.1038/nrmicro2396